Livija Šimičević

Cited by

	All	Since 2019
Citations	226	177
h-index	9	8
i10-index	6	5

2010201120122013201420152016201720182019202020212022202320245 7 3 5 1 5 8 11 20 25 33 32 51 15

Co-authors

Nada BozinaUniversity Hospital Center Zagreb, Schol of Medicine ZagrebVerified email at kbc-zagreb.hr
LANA GANOCIUniversity Hospital Centre Zagreb, School of Medicine University of ZagrebVerified email at kbc-zagreb.hr
Tamara BožinaSchool of Medicine University of ZagrebVerified email at mef.hr
Jadranka SertićTenured professor of Clin. Biochem, Faculty of Medicine Zagreb / Spec. in Med. Biochem.Verified email at kbc-zagreb.hr
Mario LaganovicDocent, Medicinski fakultet Sveučilište u ZagrebuVerified email at mef.hr
Bojan JelakovićMedicinski fakultet Sveučilišta u Zagrebu Klinički bolnički centar ZagrebVerified email at mef.hr
Vladimir TrkuljaProfesor farmakologije, Medicinski fakultet Sveučilište u ZagrebuVerified email at mef.hr
Margareta Fištrek PrlićMD, PhD, University Hospital Center ZagrebVerified email at kbc-zagreb.hr
Ivan PećinZagreb school of medicine, Professor of Internal medicine; University hospital centreVerified email at kbc-zagreb.hr
Dražen BegićProfesor psihijatrije, Medicinski fakultet, Sveučilište u ZagrebuVerified email at mef.hr
Majda Vrkić KirhmajerUniversity Hospital Center Zagreb, University of Zagreb School of MedicineVerified email at kbc-zagreb.hr
Jasna Lovrićredoviti profesor u trajnom zvanju kemije i biokemije, Sveučilište u Zagrebu, Medicinski fakultetVerified email at mef.hr
Zarko BajicUniversity Psychiatric Hospital "Sveti Ivan", Zagreb, CroatiaVerified email at biometrika.hr
Stjepko Plestinaprofessor of pathophysiologyVerified email at kbc-zagreb.hr
Živka DikaAssist Prof, School of Medcine, University of Zagreb, Šalata 3Verified email at mef.hr
Professor Alemka Markotic, MD, PhDUniversity Hospital for Infect Dis, Zagreb; Medical School, Univ of Rijeka; Catholic Univ, ZagrebVerified email at bfm.hr
Visnja SkerkUniversity Hospital for Infectious Diseases Zagreb, CroatiaVerified email at bfm.hr
Antonela Bazina MartinovićneurologistVerified email at kbc-zagreb.hr
Ivan BilicDepartment of Oncology, University Hospital Center ZagrebVerified email at kbc-zagreb.hr
Iva MucaloAssoc. Prof. University of Zagreb Faculty of Pharmacy and BiochemistryVerified email at pharma.unizg.hr

Livija Šimičević

PhD, Specialist in Medical Biochemistry and Laboratory Medicine, University Hospital Center Zagreb

Verified email at vip.hr

Pharmacogenomics Personalised medicine Precision medicine Medical Biochemistry Laboratory Medicine


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Prediction of posttraumatic stress disorder symptomatology after childbirth–A Croatian longitudinal study AS Imširagić, D Begić, L Šimičević, Ž Bajić Women and Birth 30 (1), e17-e23, 2017	53	2017
The significance of Chlamydia trachomatis in urethritis and prostatitis - Differences in therapeutic approach - Croatian experience V Škerk, L Markovinović, Š Zekan, J Jakšić, S Židovec-Lepej, A Markotić, ... Journal of chemotherapy 21 (1), 63-67, 2009	27	2009
Rosuvastatin‐induced rhabdomyolysis–Possible role of ticagrelor and patients’ Pharmacogenetic profile M Vrkić Kirhmajer, V Macolić Šarinić, L Šimičević, I Ladić, K Putarek, ... Basic & clinical pharmacology & toxicology 123 (4), 509-518, 2018	25	2018
Multivariate analysis of predictors of depression symptomatology after childbirth A Srkalović Imširagić, D Begić, I Sarajlić Vuković, L Šimićević, T Javorina Psychiatria Danubina 26 (suppl 3), 416-421, 2014	17	2014
Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review N Božina, L Ganoci, L Simičević, K Gvozdanović, I Klarica Domjanović, ... Arhiv za higijenu rada i toksikologiju 72 (2), 128-128, 2021	13	2021
Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population V Krasniqi, A Dimovski, H Qorraj Bytyqi, A Eftimov, L Šimičević, N Božina Arhiv za higijenu rada i toksikologiju 68 (3), 180-184, 2017	13	2017
DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine‐based protocols N Božina, I Bilić, L Ganoci, L Šimičević, S Pleština, L Lešnjaković, ... British journal of clinical pharmacology 88 (5), 2190-2202, 2022	9	2022
Haptoglobin genotype 2-2 associated with atherosclerosis in patients with ischemic stroke A Merkler, J Sertić, AB Martinović, T Križ, I Miličić, M Šimić, D Caban, ... Gene 752, 144786, 2020	9	2020
Use of pharmacogenomics in elderly patients treated for cardiovascular diseases IM Nada Božina, Majda Vrkić Kirhmajer, Livija Šimičević, Lana Ganoci ... CMJ 61, 147-58, 2020	9*	2020
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of … I Merćep, I Radman, V Trkulja, T Božina, L Šimičević, E Budimir, L Ganoci, ... European journal of clinical pharmacology, 1-10, 2022	8	2022
Prostate specific antigen and type 2 diabetes : A preliminary report. L Cvitković, L Sokolić, I Pavlić-Renar, B Ročić Diabetologia Croatica 30, 121-124, 2001	8	2001
Farmakogenetika/farmakogenomika u personaliziranoj medicini N Božina, L Ganoci, L Šimičević	5	2023
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? L Lešnjaković, L Ganoci, I Bilić, L Šimičević, I Mucalo, S Pleština, ... Pharmacogenomics 24 (2), 93-106, 2023	5	2023
National Guidelines for the Performance of the Sweat Test in Diagnosis of Cystic Fibrosis on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine and … J Leniček Krleža, M Aralica, D Tješić-Drinković, K Crneković, J Culej, ... Biochemia medica 32 (1), 8-23, 2022	5	2022
Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series L Šimičević, AM Slišković, MV Kirhmajer, L Ganoci, H Holik, J Palić, ... Pharmacy 11 (1), 29, 2023	3	2023
Severe hyperglycaemia following pazopanib treatment: The role of drug‐drug‐gene interactions in a patient with metastatic renal cell carcinoma—A case report. D Kuruc Poje, N Božina, L Šimičević, I Žabić Journal of Clinical Pharmacy & Therapeutics 45 (4), 2020	3	2020
Can the choice of diet undermine the potential genetic risk of AT1R 1166A> C gene polymorphism? T Božina, J Lovrić, L Šimičević, A Merkler, M Božina, B Jelaković, J Sertić Gene 679, 291-296, 2018	3	2018
Rapid clearance of tacrolimus blood concentration triggered by variant pharmacogenes. L Šimičević, I Canjuga, L Zibar, A Borić‐Bilušić, L Ganoci, N Božina Journal of Clinical Pharmacy & Therapeutics 47 (9), 2022	2	2022
FREQUENCY OF AGT, ACE, AGTR1, ADRB1, UMOD AND ADIPOQ GENETIC POLYMORPHISM IN PREHYPERTENSION L Simicevic, B Milicic, J Josipovic, K Djapic, V Domislovic, V Ivkovic, ... Journal of Hypertension (ESH 2019 Abstract Book) 37 (1), e214, 2019	2	2019
The pharmacogenomics of hypolipemics: ABCG2 as a potential predictor of hepatotoxicity N Božina, L Šimičević, I Pećin, T Božina, Ž Reiner 9. kongres Hrvatskog društva za medicinsku biokemiju i laboratorijsku …, 2018	2*	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors